aldosterone has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuda, M | 1 |
| Hirata, A | 1 |
| Tokunaga, S | 1 |
| Masuda, T | 1 |
| Haji, S | 1 |
| Kimura, D | 1 |
| Nojiri, C | 1 |
| Nakashima, Y | 1 |
| Shiratsuchi, M | 1 |
| Kato, K | 1 |
| Miyamoto, T | 1 |
| Akashi, K | 1 |
| Nakashima, N | 1 |
| Ogawa, Y | 1 |
| Neguliaev, IuA | 1 |
| Vedernikova, EA | 1 |
| Maksimov, AV | 1 |
2 other studies available for aldosterone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.
Topics: Aldosterone; Angiotensins; Antihypertensive Agents; Enzyme Inhibitors; Glomerular Filtration Rate; H | 2022 |
[Aldosterone increases the activity level of Na+-conducting channels in chronic myeloid leukemia K562 cells].
Topics: Aldosterone; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Patch-Clamp Techniques; Sodiu | 1996 |